Ad
Saturday, 2 June 2018
Roche drugs show limited benefit in lung, breast cancer trials
CHICAGO (Reuters) - In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials presented on Saturday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment